China Sxt Pharmaceuticals Inc
(SXTC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 03-2025 | 09-2024 | 03-2024 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,369 | -3,304 | -803 | -3,099 | -9,696 |
| Depreciation Amortization | 32 | 82 | 69 | 203 | 103 |
| Accounts receivable | 100 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -646 | N/A | N/A | N/A | N/A |
| Other Working Capital | -993 | -972 | -746 | -382 | 316 |
| Other Operating Activity | 6,122 | 1,849 | 124 | 1,350 | 8,697 |
| Operating Cash Flow | $-1,753 | $-2,345 | $-1,357 | $-1,928 | $-580 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 64 | 41 | -7 | N/A |
| Other Investing Activity | -925 | 0 | 0 | 34 | 20 |
| Investing Cash Flow | $-925 | $64 | $41 | $26 | $20 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 307 | N/A | N/A | N/A | N/A |
| Debt Repayment | -115 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 5,179 | 8,399 | 7,237 | -2,624 | -4,462 |
| Financing Cash Flow | $5,371 | $8,399 | $7,237 | $-2,624 | $-4,462 |
| Exchange Rate Effect | 374 | -65 | 515 | -765 | -882 |
| Beginning Cash Position | 18,129 | 12,077 | 12,077 | 17,368 | 17,368 |
| End Cash Position | 21,198 | 18,129 | 18,513 | 12,077 | 11,465 |
| Net Cash Flow | $3,068 | $6,052 | $6,436 | $-5,291 | $-5,903 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,753 | -2,345 | -1,357 | -1,928 | -580 |
| Free Cash Flow | -1,753 | -2,345 | -1,357 | -1,928 | -580 |